SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$25.35
+6.65%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 220.7M | 200.9M | 167.2M | 138.9M | 106.4M |
| Cost of Revenue | 45.5M | 41.0M | 35.1M | 29.5M | 15.7M |
| Gross Profit | 175.2M | 159.9M | 132.1M | 109.4M | 90.7M |
| Operating Expenses | |||||
| R&D Expense | 18.3M | 17.4M | 16.6M | 15.0M | 13.6M |
| SG&A Expense | 173.6M | 164.8M | 150.8M | 141.3M | 136.7M |
| General & Admin Expense | 40.1M | 40.5M | 33.8M | 31.1M | 29.0M |
| Selling & Marketing Expense | 133.5M | 124.2M | 117.1M | 110.3M | 107.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 191.9M | 182.2M | 167.4M | 156.4M | 150.3M |
| Cost and Expenses | 237.4M | 223.3M | 202.4M | 185.8M | 166.0M |
| Operating Income (EBIT) | (16.7M) | (22.3M) | (35.2M) | (46.9M) | (59.6M) |
| Non-Operating | |||||
| Interest Income | 5.5M | 6.1M | 7.8M | 6.9M | 1.3M |
| Interest Expense | 2.4M | 5.3M | 3.4M | 3.5M | 2.8M |
| Net Interest Income | 3.0M | 790.0K | 4.4M | 3.5M | (1.5M) |
| Other Non-Op Income/Expense | 3.0M | 3.4M | 4.3M | 3.6M | (1.6M) |
| Non-Operating Income (excl Interest) | (4.1M) | (8.7M) | (7.8M) | (7.1M) | (1.2M) |
| EBT (Pre-Tax Income) | (13.7M) | (18.9M) | (30.9M) | (43.3M) | (61.3M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (13.7M) | (18.9M) | (30.9M) | (43.3M) | (61.3M) |
| Earnings from Cont. Ops | (13.7M) | (18.9M) | (30.9M) | (43.3M) | (61.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (13.7M) | (18.9M) | (30.9M) | (43.3M) | (61.3M) |
| Per Share | |||||
| Basic EPS | ($0.31) | ($0.44) | ($0.75) | ($1.13) | ($1.79) |
| Diluted EPS | ($0.31) | ($0.44) | ($0.75) | ($1.13) | ($1.79) |
| Revenue Per Share | $4.91 | $4.62 | $4.03 | $3.61 | $3.11 |
| Shares | |||||
| Basic Shares Outstanding | 44.9M | 43.5M | 41.5M | 38.4M | 34.2M |
| Diluted Shares Outstanding | 44.9M | 43.5M | 41.5M | 38.4M | 34.2M |
| Profitability Metrics | |||||
| EBITDA | (3.9M) | (10.9M) | (23.1M) | (34.4M) | (55.0M) |
| D&A | 8.7M | 2.7M | 4.4M | 5.4M | 3.5M |
| EBIT | (12.6M) | (13.6M) | (27.5M) | (39.9M) | (58.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026